Phase I trial of continous infusion 5-fluorouracil (CI-5FU) and escalating doses of oxaliplatin (OXA) given weekly with concurrent radiation (RT) in locally advanced esophageal squamous cell carcinoma (ESCC). Conference

Brücher, BL, Zimmermann, F, Riera, J et al. (2005). Phase I trial of continous infusion 5-fluorouracil (CI-5FU) and escalating doses of oxaliplatin (OXA) given weekly with concurrent radiation (RT) in locally advanced esophageal squamous cell carcinoma (ESCC). . JOURNAL OF CLINICAL ONCOLOGY, 23(16), 374S-374S.

Industry Collaboration

cited authors

  • Brücher, BL; Zimmermann, F; Riera, J; Becker, K; Roethling, N; Seroneit, T; Molls, M; Peschel, C; Siewert, JR; Lordick, F

authors

date/time interval

  • May 13, 2005 -

publication date

  • June 1, 2005

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • FL, Orlando

Conference

  • 41st Annual Meeting of the American-Society-of-Clinical-Oncology

publisher

  • AMER SOC CLINICAL ONCOLOGY

start page

  • 374S

end page

  • 374S

volume

  • 23

issue

  • 16